At UBI Pharma, we not only have R&D experts specialized in the development and production of protein drugs and specialty injectable drug products, we also have talents across the fields of clinical studies, regulatory affairs, pharmaceutical manufacturing and management. Our current capacity for injectable vial production is 11.2 million vials annually. In addition, we expanded our production line capacity for injectable vials in 2021, which is expected to increase fourfold in 2023. We are dedicated to providing timely business, technical, and manufacturing services to customers around the globe. As of June 2022, UBI Pharma has over 250 employees.